ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy in Europe, Canada and Other Geographies Outside the United States
| CAMUX Fund | USD 25.86 0.03 0.12% |
Slightly above 62% of Cambiar Smid's investor base is looking to short. The analysis of overall sentiment of trading Cambiar Smid Fund mutual fund suggests that many investors are alarmed at this time. Cambiar Smid's investing sentiment can be driven by a variety of factors including economic data, Cambiar Smid's earnings reports, geopolitical events, and overall market trends.
Cambiar |
Agreement leverages ALKs global footprint in developing and commercializing innovative allergy products ARS Pharma to receive an upfront cash payment of...
Read at globenewswire.com
 |
Cambiar Smid Fundamental Analysis
We analyze Cambiar Smid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cambiar Smid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cambiar Smid based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Cambiar Smid is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Cambiar Smid Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cambiar Smid mutual fund to make a market-neutral strategy. Peer analysis of Cambiar Smid could also be used in its relative valuation, which is a method of valuing Cambiar Smid by comparing valuation metrics with similar companies.
Peers
Cambiar Smid Related Equities
| CAMYX | Cambiar International | 1.25 | ||||
| CAMIX | Cambiar International | 1.25 | ||||
| CAMWX | Cambiar Opportunity | 0.36 | ||||
| CAMOX | Cambiar Opportunity | 0.36 | ||||
| CAMSX | Cambiar Small | 0.22 | ||||
| CAMZX | Cambiar Small | 0.21 | ||||
| CAMMX | Cambiar Smid | 0.12 |
Other Information on Investing in Cambiar Mutual Fund
Cambiar Smid financial ratios help investors to determine whether Cambiar Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cambiar with respect to the benefits of owning Cambiar Smid security.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |